| Financial Year |
March 31 2023 |
| Monetary Funds |
526,017,951.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
854,530,418.60 |
| Advances to Suppliers |
20,696,696.79 |
| Other Receivables |
95,411,158.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
284,781,755.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,088,484.36 |
| Total Current Assets |
1,984,604,817.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
175,459,989.95 |
| Long-term Equity Investment |
195,595,930.63 |
| Investment Properties |
26,827,137.06 |
| Fixed Assetes |
658,379,562.50 |
| Under-construction Projects |
6,921,592.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
172,592,956.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
728,470.64 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
6,370,947.71 |
| Sub-Total of Non-Current Assets |
1,252,906,084.86 |
| Total Assets |
3,237,510,902.70 |
| Short-Term Loans |
1,026,707,753.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
499,658,681.47 |
| Accounts Payable |
917,113,837.47 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,698,660.73 |
| Taxes Payable |
6,901,412.42 |
| Interest Payable |
-- |
| Dividend Payable |
1,652.82 |
| Other payables |
277,124,486.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
113,229,472.22 |
| Other Current Liabilities |
3,003,566.82 |
| Sub-Total of Current Liabilities |
2,945,090,121.91 |
| Long-term Loans |
154,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
45,887.85 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,054,424.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
246,612,920.34 |
| Total Liabilities |
3,191,703,042.25 |
| Paid-In Capital(Or Share Stock) |
733,329,168.00 |
| Capital Surplus |
530,403,961.24 |
| Surplus Reserve |
47,367,283.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,338,834,335.56 |
| Minority Stockholder's Interest |
44,565,817.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,242,043.11 |
| Owner's Equity（Stockholder's Equity） |
45,807,860.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,237,510,902.70 |
